Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review

BACKGROUND: Anti-interleukin (IL)-17 biological agents (BAs) have significant efficacy in the treatment of psoriasis and psoriatic arthritis; however, adverse events (AEs) are common, and their safety has not been systematically evaluated. OBJECTIVES: The purpose of this systematic review and meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiao, Wang, Chunxiao, Liu, Liu, Hong, Seokgyeong, Ru, Yi, Sun, Xiaoying, Chen, Jiale, Zhang, Miao, Lin, Naixuan, Li, Bin, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928578/
https://www.ncbi.nlm.nih.gov/pubmed/36817423
http://dx.doi.org/10.3389/fimmu.2023.993057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928578/
https://www.ncbi.nlm.nih.gov/pubmed/36817423
http://dx.doi.org/10.3389/fimmu.2023.993057

Ejemplares similares